Follicular Lymphoma Treatment Market Report

Global and Region Follicular Lymphoma Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：223
  • REPORT CODE：GMM984057
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Follicular Lymphoma Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Follicular Lymphoma Treatmentmarket, defines the market attractiveness level of Follicular Lymphoma Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Follicular Lymphoma Treatment industry, describes the types of Follicular Lymphoma Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Follicular Lymphoma Treatment market and the development prospects and opportunities of Follicular Lymphoma Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Follicular Lymphoma Treatment market in Chapter 13.

    By Player:

    • Curis Inc

    • ImmunoGen Inc

    • Hutchison MediPharma Limited

    • EpiZyme Inc

    • GlaxoSmithKline Plc

    • Coherus BioSciences Inc

    • Cellular Biomedicine Group Inc

    • Celldex Therapeutics Inc

    • CTI BioPharma Corp

    • Celgene Corporation

    • Boehringer Ingelheim GmbH

    • Genentech Inc

    • Celltrion Inc

    • Eisai

    • Immune Design Corp

    • Bristol-Myers Squibb Company

    • Gilead Sciences Inc

    • F Hoffmann-La Roche Ltd

    • Dynavax Technologies Corporation

    By Type:

    • Chemotherapy

    • Radiotherapy

    • Monoclonal Antibodies

    • Stem Cell Transplantation

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Follicular Lymphoma Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Follicular Lymphoma Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Follicular Lymphoma Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Follicular Lymphoma Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Follicular Lymphoma Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Follicular Lymphoma Treatment Consumption (2017-2022)

    • 7.2 United States Follicular Lymphoma Treatment Consumption (2017-2022)

    • 7.3 Europe Follicular Lymphoma Treatment Consumption (2017-2022)

    • 7.4 China Follicular Lymphoma Treatment Consumption (2017-2022)

    • 7.5 Japan Follicular Lymphoma Treatment Consumption (2017-2022)

    • 7.6 India Follicular Lymphoma Treatment Consumption (2017-2022)

    • 7.7 South Korea Follicular Lymphoma Treatment Consumption (2017-2022)

    8 Region and Country-wise Follicular Lymphoma Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Follicular Lymphoma Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Follicular Lymphoma Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Follicular Lymphoma Treatment Consumption Forecast (2022-2028)

    • 8.4 China Follicular Lymphoma Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Follicular Lymphoma Treatment Consumption Forecast (2022-2028)

    • 8.6 India Follicular Lymphoma Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Follicular Lymphoma Treatment Consumption Forecast (2022-2028)

    9 Global Follicular Lymphoma Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Follicular Lymphoma Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Radiotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Stem Cell Transplantation Consumption and Growth Rate (2017-2022)

    • 9.2 Global Follicular Lymphoma Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Follicular Lymphoma Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Follicular Lymphoma Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Stem Cell Transplantation Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Follicular Lymphoma Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Follicular Lymphoma Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Follicular Lymphoma Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Follicular Lymphoma Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Follicular Lymphoma Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Follicular Lymphoma Treatment Market Competitive Analysis

    • 14.1 Curis Inc

      • 14.1.1 Curis Inc Company Details

      • 14.1.2 Curis Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Curis Inc Follicular Lymphoma Treatment Product and Service

    • 14.2 ImmunoGen Inc

      • 14.2.1 ImmunoGen Inc Company Details

      • 14.2.2 ImmunoGen Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 ImmunoGen Inc Follicular Lymphoma Treatment Product and Service

    • 14.3 Hutchison MediPharma Limited

      • 14.3.1 Hutchison MediPharma Limited Company Details

      • 14.3.2 Hutchison MediPharma Limited Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Hutchison MediPharma Limited Follicular Lymphoma Treatment Product and Service

    • 14.4 EpiZyme Inc

      • 14.4.1 EpiZyme Inc Company Details

      • 14.4.2 EpiZyme Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 EpiZyme Inc Follicular Lymphoma Treatment Product and Service

    • 14.5 GlaxoSmithKline Plc

      • 14.5.1 GlaxoSmithKline Plc Company Details

      • 14.5.2 GlaxoSmithKline Plc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GlaxoSmithKline Plc Follicular Lymphoma Treatment Product and Service

    • 14.6 Coherus BioSciences Inc

      • 14.6.1 Coherus BioSciences Inc Company Details

      • 14.6.2 Coherus BioSciences Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Coherus BioSciences Inc Follicular Lymphoma Treatment Product and Service

    • 14.7 Cellular Biomedicine Group Inc

      • 14.7.1 Cellular Biomedicine Group Inc Company Details

      • 14.7.2 Cellular Biomedicine Group Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Cellular Biomedicine Group Inc Follicular Lymphoma Treatment Product and Service

    • 14.8 Celldex Therapeutics Inc

      • 14.8.1 Celldex Therapeutics Inc Company Details

      • 14.8.2 Celldex Therapeutics Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Celldex Therapeutics Inc Follicular Lymphoma Treatment Product and Service

    • 14.9 CTI BioPharma Corp

      • 14.9.1 CTI BioPharma Corp Company Details

      • 14.9.2 CTI BioPharma Corp Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 CTI BioPharma Corp Follicular Lymphoma Treatment Product and Service

    • 14.10 Celgene Corporation

      • 14.10.1 Celgene Corporation Company Details

      • 14.10.2 Celgene Corporation Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Celgene Corporation Follicular Lymphoma Treatment Product and Service

    • 14.11 Boehringer Ingelheim GmbH

      • 14.11.1 Boehringer Ingelheim GmbH Company Details

      • 14.11.2 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Product and Service

    • 14.12 Genentech Inc

      • 14.12.1 Genentech Inc Company Details

      • 14.12.2 Genentech Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Genentech Inc Follicular Lymphoma Treatment Product and Service

    • 14.13 Celltrion Inc

      • 14.13.1 Celltrion Inc Company Details

      • 14.13.2 Celltrion Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Celltrion Inc Follicular Lymphoma Treatment Product and Service

    • 14.14 Eisai

      • 14.14.1 Eisai Company Details

      • 14.14.2 Eisai Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Eisai Follicular Lymphoma Treatment Product and Service

    • 14.15 Immune Design Corp

      • 14.15.1 Immune Design Corp Company Details

      • 14.15.2 Immune Design Corp Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Immune Design Corp Follicular Lymphoma Treatment Product and Service

    • 14.16 Bristol-Myers Squibb Company

      • 14.16.1 Bristol-Myers Squibb Company Company Details

      • 14.16.2 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Product and Service

    • 14.17 Gilead Sciences Inc

      • 14.17.1 Gilead Sciences Inc Company Details

      • 14.17.2 Gilead Sciences Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Gilead Sciences Inc Follicular Lymphoma Treatment Product and Service

    • 14.18 F Hoffmann-La Roche Ltd

      • 14.18.1 F Hoffmann-La Roche Ltd Company Details

      • 14.18.2 F Hoffmann-La Roche Ltd Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 F Hoffmann-La Roche Ltd Follicular Lymphoma Treatment Product and Service

    • 14.19 Dynavax Technologies Corporation

      • 14.19.1 Dynavax Technologies Corporation Company Details

      • 14.19.2 Dynavax Technologies Corporation Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Dynavax Technologies Corporation Follicular Lymphoma Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Follicular Lymphoma Treatment

    • Figure Follicular Lymphoma Treatment Picture

    • Table Global Follicular Lymphoma Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Follicular Lymphoma Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Follicular Lymphoma Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Follicular Lymphoma Treatment Consumption by Country (2017-2022)

    • Figure United States Follicular Lymphoma Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Follicular Lymphoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Follicular Lymphoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Follicular Lymphoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Follicular Lymphoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Follicular Lymphoma Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Follicular Lymphoma Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Follicular Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Follicular Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Follicular Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Follicular Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Follicular Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Follicular Lymphoma Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Radiotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Stem Cell Transplantation Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stem Cell Transplantation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Follicular Lymphoma Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Follicular Lymphoma Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Curis Inc (Foundation Year, Company Profile and etc.)

    • Table Curis Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Curis Inc Follicular Lymphoma Treatment Product and Service

    • Table ImmunoGen Inc (Foundation Year, Company Profile and etc.)

    • Table ImmunoGen Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table ImmunoGen Inc Follicular Lymphoma Treatment Product and Service

    • Table Hutchison MediPharma Limited (Foundation Year, Company Profile and etc.)

    • Table Hutchison MediPharma Limited Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hutchison MediPharma Limited Follicular Lymphoma Treatment Product and Service

    • Table EpiZyme Inc (Foundation Year, Company Profile and etc.)

    • Table EpiZyme Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table EpiZyme Inc Follicular Lymphoma Treatment Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Follicular Lymphoma Treatment Product and Service

    • Table Coherus BioSciences Inc (Foundation Year, Company Profile and etc.)

    • Table Coherus BioSciences Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Coherus BioSciences Inc Follicular Lymphoma Treatment Product and Service

    • Table Cellular Biomedicine Group Inc (Foundation Year, Company Profile and etc.)

    • Table Cellular Biomedicine Group Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cellular Biomedicine Group Inc Follicular Lymphoma Treatment Product and Service

    • Table Celldex Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Celldex Therapeutics Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celldex Therapeutics Inc Follicular Lymphoma Treatment Product and Service

    • Table CTI BioPharma Corp (Foundation Year, Company Profile and etc.)

    • Table CTI BioPharma Corp Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table CTI BioPharma Corp Follicular Lymphoma Treatment Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Follicular Lymphoma Treatment Product and Service

    • Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Product and Service

    • Table Genentech Inc (Foundation Year, Company Profile and etc.)

    • Table Genentech Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Inc Follicular Lymphoma Treatment Product and Service

    • Table Celltrion Inc (Foundation Year, Company Profile and etc.)

    • Table Celltrion Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Inc Follicular Lymphoma Treatment Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Follicular Lymphoma Treatment Product and Service

    • Table Immune Design Corp (Foundation Year, Company Profile and etc.)

    • Table Immune Design Corp Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immune Design Corp Follicular Lymphoma Treatment Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Follicular Lymphoma Treatment Product and Service

    • Table Gilead Sciences Inc (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Inc Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Inc Follicular Lymphoma Treatment Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Follicular Lymphoma Treatment Product and Service

    • Table Dynavax Technologies Corporation (Foundation Year, Company Profile and etc.)

    • Table Dynavax Technologies Corporation Follicular Lymphoma Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dynavax Technologies Corporation Follicular Lymphoma Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US